Manas AI

Based in the United States, Manas AI is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Manas AI develops an AI-native biopharmaceutical platform that accelerates drug discovery by integrating physics-based and biologically informed AI models to improve the speed, cost efficiency, and precision of developing therapeutics across multiple modalities such as small molecules, antibodies, and siRNA.